Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T-Cell Engager, in Prostate Cancer Patients - Kuipers-Connarn, Jamie N; Pourzanjani, Arya; Bose, Maitreyee; Modi, Saurabh; Stieglmaier, Julia; Murphy, Alexis; Mehta, Khamir; Upreti, Vijay V (Journal of clinical pharmacology, 2025)
Keywords: modeling and simulation; drug development; clinical pharmacology; clinical trials; oncology